Nifty Midcap 150 with High ROCE

The table below shows the nifty midcap 150 with a high ROCE based on the Highest Market Capitalization.

What Are The Nifty Midcap 150 with High ROCE?

Nifty Midcap 150 with high ROCE refers to companies in the midcap segment that demonstrate strong financial efficiency, measured by Return on Capital Employed (ROCE). High ROCE indicates effective utilization of capital to generate profits, reflecting operational excellence, robust financial health, and sustainable growth potential, making these companies attractive to investors seeking quality midcap stocks with sound returns.

Features Of Niftymidcap 150 with High ROCE

The features of Nifty Midcap 150 with high ROCE include strong financial health, operational efficiency, and sustainable growth potential, making them attractive to investors.

1. Robust Profitability: High ROCE signifies efficient capital use, leading to greater profitability and shareholder value.
2. Operational Excellence: Demonstrates effective management and operational processes contributing to superior performance.
3. Strong Financial Stability: Companies with high ROCE often have solid balance sheets and lower debt levels.
4. Growth Potential: Indicates a company’s capability to generate high returns, signalling future growth opportunities.
5. Investor Confidence: Attracts more investors due to strong performance metrics and financial health.

Best Niftymidcap 150 with High ROCE

The table below shows the best nifty midcap 150 with high roce based on the highest day Volume.

Top Niftymidcap 150 with High ROCE in India

The table below shows the top nifty midcap 150 with high roce in India based on 1 Year Return. 

Factors To Consider When Investing In Nifty Midcap 150 with High ROCE

The factors to consider when investing in Nifty midcap 150 with high ROCE include understanding the company’s financial health and sustainability of high returns.

1. Market Position: Evaluate if the company holds a strong market position to sustain high ROCE.
2. Growth Potential: Assess the potential for future growth to ensure continued profitability.
3. Debt Levels: Low debt levels often correlate with higher ROCE, indicating efficient capital use.
4. Management Efficiency: Strong management can drive high ROCE through strategic decisions.
5. Economic Conditions: Consider how macroeconomic factors might affect the company’s performance and ROCE.

How To Invest In Niftymidcap 150 with High ROCE?

To invest in Nifty Midcap 150 with high ROCE, open a trading account with a reputable broker like Alice Blue. Research and select companies with high ROCE from the Nifty Midcap 150 index. Regularly monitor your investments and adjust your portfolio accordingly. For account opening, visit Alice Blue Online.

Advantages Of Investing In Niftymidcap 150 with High ROCE

The primary advantage of investing in Niftymidcap 150 with high ROCE is the potential for superior returns due to efficient capital utilization.

1. Higher Returns: Companies with high ROCE often provide better returns on investment.
2. Stable Performance: High ROCE indicates consistent and reliable financial performance.
3. Efficient Use of Capital: Indicates effective management and utilization of company resources.
4. Attractive Valuation: High ROCE stocks can be undervalued, offering investment opportunities.
5. Competitive Edge: Companies with high ROCE typically have a strong competitive advantage in their sector.

Risks Of Investing In Niftymidcap 150 with High ROCE

The main risk of investing in the Nifty Midcap 150 with high ROCE is the potential for market volatility, which can impact midcap stocks significantly.

1. Market Volatility: Midcap stocks are more susceptible to market fluctuations and economic changes.
2. Liquidity Risk: Lower liquidity compared to large-cap stocks can affect buying and selling.
3. Economic Sensitivity: Midcaps are often more sensitive to economic cycles and downturns.
4. Management Risk: Dependence on key management decisions can be a risk factor.
5. Regulatory Changes: Potential for adverse effects from changes in industry regulations.

Introduction to Niftymidcap 150 with High ROCE 

Hindustan Zinc Ltd

The Market Cap of Hindustan Zinc Ltd is Rs. 275406.29 crores. The stock’s monthly return is -5.26%. Its one-year return is 94.84%. The stock is 30.88% away from its 52-week high.

Hindustan Zinc Limited, an India-based company, is involved in mineral exploration, extraction, processing, and the manufacturing of metals and alloys. The company’s product range includes zinc, lead, silver, commercial power, and alloys. 

Hindustan Zinc Limited operates in segments such as Zinc, Lead, Silver & others, and Wind energy. The company runs five zinc-lead mines, four zinc smelters, one lead smelter, one zinc-lead smelter, eight sulfuric acid plants, one silver refinery plant, six captive thermal power plants, and four captive solar plants in Rajasthan. 

Suzlon Energy Ltd

The Market Cap of Suzlon Energy Ltd is Rs. 97,286.22 crores. The stock’s monthly return is 31.45%. Its one-year return is 263.81%. The stock is 5.59% away from its 52-week high.

Suzlon Energy Limited, an India-based provider of renewable energy solutions, specializes in manufacturing wind turbine generators (WTGs) and related components in various capacities. The company operates in around 17 countries spanning Asia, Australia, Europe, Africa and the Americas.

Its product range includes the S144, S133, and S120 Wind Turbine Generators. Suzlon Energy Limited also provides a range of services including operations and maintenance, leadership, optimization, digitalization, value-added products, and multi-brand maintenance services.

Solar Industries India Ltd

The Market Cap of Solar Industries India Ltd is Rs. 96,248.39 crores. The stock’s monthly return is -14.16%. Its one-year return is 166.10%. The stock is 28.80% away from its 52-week high.

Solar Industries India Limited is an India-based company specializing in integrated global explosives. The company primarily focuses on manufacturing a wide range of industrial explosives and explosive-initiating devices within its Explosives and accessories segment. 

Its product offerings include packaged emulsion explosives, bulk explosives, explosive initiating systems, as well as defence-related items such as high-energy materials like HMX, RDX, TNT, and associated compounds.  

Indian Hotels Company Ltd

The Market Cap of Indian Hotels Company Ltd is Rs. 89,505.42 crore. The stock’s monthly return is 2.11%. Its one-year return is 54.46%. The stock is 8.82% away from its 52-week high.

The Indian Hotels Company Limited, based in India, is a hospitality company that specializes in owning, operating, and managing hotels, palaces, and resorts. 

Its diverse portfolio includes premium and luxury hotel brands as well as various F&B, wellness, salon, and lifestyle brands. Some of its well-known brands are Taj, SeleQtions, Vivanta, Ginger, ama Stays & Trails, and more. Taj, the company’s flagship brand, has around 100 hotels, with 81 currently operational and 19 in the development pipeline. 

Lupin Ltd

The Market Cap of Lupin Ltd is Rs 89,447.59 crores. The stock’s monthly return is 11.05%. Its one-year return is 80.20%. The stock is 1.83% away from its 52-week high.

Lupin Limited, an India-based pharmaceutical company, focuses on producing, developing, and marketing a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) on a global scale. 

The company operates in various therapeutic segments such as Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives, Nonsteroidal Anti Inflammatory Drug therapy, Anti-TB, and Cephalosporins.  

Max Healthcare Institute Ltd

The Market Cap of Max Healthcare Institute Ltd is Rs. 89,057.58 crore. The stock’s monthly return is -0.31%. Its one-year return is 48.41%. The stock is 13.19% away from its 52-week high.

Max Healthcare Institute Limited is an Indian healthcare company that operates within the Medical and Healthcare Services sector. 

Max Healthcare Institute Limited specializes in a variety of medical fields, including cancer care/oncology, cardiac sciences, endocrinology, eye care/ophthalmology, gastroenterology, hepatology, laparoscopic surgery, neurosciences, liver and biliary sciences, orthopaedics, bariatric surgery, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery.  

HDFC Asset Management Company Ltd

The Market Cap of HDFC Asset Management Company Ltd is Rs. 88,075.58 crores. The stock’s monthly return is -2.44%, while its one-year return is 64.42%. The stock is 6.62% away from its 52-week high.

HDFC Asset Management Company Limited serves as a mutual fund manager, offering asset management services to HDFC Mutual Fund as well as providing portfolio management and advisory services to clients. 

Their range of products includes various investment options, such as mutual funds (both active and passive), portfolio management services, and alternative investment opportunities designed to meet the diverse needs of their customers. The company also offers financial management, advisory, brokerage, and consulting services, with a widespread network of 228 investor service centres in over 200 cities.  

Aurobindo Pharma Ltd

The Market Cap of Aurobindo Pharma Ltd is Rs. 84,568.52 crore. The stock’s monthly return is 14.99%. Its one-year return is 63.69%. The stock is 2.08% away from its 52-week high.

Aurobindo Pharma Limited is an Indian pharmaceutical company that specializes in manufacturing and marketing various pharmaceutical products and services. 

The company’s product range covers seven therapeutic areas including Central Nervous System, Antiretrovirals, Cardiovascular, Oral and Sterile products, Anti-infectives, Anti-diabetics, and Oral Cephalosporins.  

Godrej Properties Ltd

The Market Cap of Godrej Properties Ltd is Rs. 83,460.19 crore. The stock’s monthly return is -9.19%. Its one-year return is 92.20%. The stock is 20.01% away from its 52-week high.

Godrej Properties Limited, an India-based company, specializes in real estate construction, development, and related activities. The company focuses on developing real estate properties under the Godrej brand. 

Some of its prominent projects include Godrej Avenues, Godrej Reserve, Godrej Icon, Godrej Air – Phase 1, Godrej 101, Godrej United, Godrej Platinum, and Godrej Two. Godrej Properties has a presence in various regions including Mumbai Metropolitan Region (MMR), National Capital Region, Pune, Bangalore, Kolkata, Ahmedabad, Nagpur, Chennai, and Chandigarh.  

Mankind Pharma Ltd

The Market Cap of Mankind Pharma Ltd is Rs. 80,129.03 crores. The stock’s monthly return is -7.84%. Its one-year return is 10.36%. The stock is 25.10% away from its 52-week high.

Mankind Pharma Limited is an Indian pharmaceutical company that is involved in the development, production, and promotion of a wide range of pharmaceutical products across various acute and chronic health conditions, as well as consumer healthcare items. 

The company offers a variety of formulations in therapeutic categories like anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynaecology, and pain relief, among others.  

Top Niftymidcap 150 with High ROCE – FAQs

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.